Global Diaphragm Pacing Therapy System Market by Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global diaphragm pace therapy system market was valued at USD 7.6 millions in 2020. It is expected to grow at a compound annual rate (CAGR of 4.6%) between 2021 and 2028. Market growth is expected to be supported by the growing number of disorders such as sleep apnea and amyotrophiclateral sclerosis. The diaphragm pacemaker is more accurate, comfortable compared to the mechanical ventilators and reduces the risk of upper airway infections such as ventilator-associated pneumonia. The adoption of diaphragm-pacing therapy systems is also being encouraged by the positive regulatory policies and approvals. Due to an increase in ventilation requirements for patients infected with COVID-19, the demand has increased.

The diaphragm-pacing therapy system decreases dependence on manual ventilators. Most patients prefer the diaphragm ratemaker because it facilitates normal breathing, better speech patterns, improved smell, ease of drinking, and easier eating. The silent operation and functionality of a breathing pacemaker, as well as the small size that allows mobility, are expected to increase the popularity of diaphragm-pacing therapy systems.

Product Insights

The market was dominated by the segment of external diaphragm pacemaker in 2020. It accounted for the largest revenue share at 57.8%. The market for diaphragm-pacing therapy systems can be divided into two segments based on product: external diaphragm and diaphragm.

Due to increasing treatment for conditions like congenital central hypoventilation and cervical spinal cord injury, the external diaphragm ratemaker segment is growing in popularity. Market growth is further supported by the diaphragm pacemaker's ability to reduce power outages and external power supply requirements. The market also benefits from the ease of movement and quiet functioning.

Application Insights

Due to the increasing number of spinal cord injuries worldwide, the spinal cord injury segment dominated and accounted for 45.5% of the total market revenue in 2020. The National Spinal Cord Injury Statistical Center reports that approximately 17,000 new cases of spinal cord injuries are reported each year in the U.S.

The increase in injuries sustained in sports and recreation activities and accidents, as well as the increased incidence of spinal cord injury, has led to a rise in demand for diaphragm pace therapy systems. Market growth for diaphragm-pacing therapy systems is expected to be supported by the rising incidence of amyotrophiclateral sclerosis. Amyotrophic lateral syndrome is more common in older people. It is estimated that approximately 5,000 new cases of the disease are diagnosed annually in the United States.

Regional Insights

North America was the dominant market for diaphragm-pacing therapy systems in 2020, accounting for the largest revenue share at 59.7%. Due to the high prevalence of breathing disorders such as sleep apnea and amytrophic lateral syndrome, the market will grow in the region during the forecast period. Market growth is expected to be aided by the rising healthcare spending and growing disposable incomes.

The market in Asia Pacific is expected to grow at the fastest rate during the forecast period. This is due to rising incidence of breathing disorders, increasing healthcare expenditure, supportive government initiatives and growing focus on R&D activities to improve the healthcare infrastructure.

Market Share Insights & Key Companies

The market players have been able to innovate and develop further to meet growing demand due to technological developments in healthcare. The ongoing COVID-19 epidemic has led to a surge in critical patients who require mechanical ventilation for prolonged periods. The increased demand for ventilators has weighed on the ICU and healthcare systems. Patients are at risk of developing ventilator-induced diaphragm dysfunction. Lungpacer Medical's diaphragm pacing treatment system was granted the U.S. FDA Emergency Use Authorization (April 2020) for COVID-19 patients.

Synapse Biomedical also received an Emergency Use Authorization from the U.S. FDA to use its TransAeris diaphragm-pacing therapy system. In 2018, TransAeris received CE Mark approval and is currently under clinical investigation in the U.S. The market leader in diaphragm-pacing therapy systems is:

• Lungpacer Medical Inc.

• Avery Biomedical Devices, Inc.

• Synapse Biomedical

• Atrotech

Up Market Research published a new report titled “Diaphragm Pacing Therapy System Market research report which is segmented by Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis), By Players/Companies Avery Biomedical Devices Inc, Synapse Biomedical, Lungpacer Medical Inc, Atrotech”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Diaphragm Pacing Therapy System Market Report Segments:

The market is segmented by Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis).

Diaphragm Pacing Therapy System Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Diaphragm Pacing Therapy System Market

Overview of the regional outlook of the Diaphragm Pacing Therapy System Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Diaphragm Pacing Therapy System Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Diaphragm Pacing Therapy System Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Spinal Cord Injury

                2. Amyotrophic Lateral Sclerosis

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Diaphragm Pacing Therapy System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Diaphragm Pacing Therapy System Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.